Candel Therapeutics Stock (NASDAQ: CADL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 110.00 / 379.22K |
Day Range | - - - |
52 Wk Range | 0.66 - 14.30 |
Market Cap | $227.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 7.65% |
Days to Cover | 8.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Candel Therapeutics (NASDAQ:CADL) through any online brokerage.
Other companies in Candel Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Adaptimmune Therapeutics (NASDAQ:ADAP) and Sangamo Therapeutics (NASDAQ:SGMO).
Candel Therapeutics has a consensus price target of $8.25.
The stock price for Candel Therapeutics (NASDAQ: CADL) is $7.1 last updated September 24, 2024 at 7:14 AM EDT.
There are no upcoming dividends for Candel Therapeutics.
Candel Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Candel Therapeutics.
Candel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.